Brian Krob is a partner in Nixon Peabody's Corporate practice group. He represents corporate acquirers as well as private equity firms in their acquisitions and dispositions.
I represent public and private companies in strategic corporate transactions, including acquisitions, dispositions, joint ventures, and investments. I work with clients across industries, with a particular focus in the technology, healthcare, and consumer verticals.
For my entire career, I have represented private equity funds in the acquisition and disposition of their portfolio companies. While the company is being held by the private equity fund, I work with management to resolve their day-to-day legal issues as they arise, with an ultimate view to preparing the company for disposition by the fund.
Complexity in transactions will continue to rise. Almost all transactions now have international elements to them, whether representing an entity with foreign operations, a U.S. business seeking to make an acquisition abroad or a foreign investor seeking to deploy capital in the U.S. All of this is in a rising tide of uncertainty. Excellent counsel can provide practical legal strategies for managing these complexities.
University of Illinois College of Law, J.D., magna cum laude, Order of the Coif
Brian has been recommended in The Legal 500 United States 2021 editorial for M&A/Corporate and commercial—M&A: Middle-market (sub-$500m). He has also been recognized in previous years.
As a participant in Law360's Q&A series with dealmaking movers and shakers, Brian Krob shared his perspective on five questions.
Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe